# Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-techniques-for-monitoring-infliximab-and-antibodies-against/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Casper Steenholdt,Mark Ainsworth,Michaël G. Tovey,Tobias Wirenfeldt Klausen,Ole Østergaard Thomsen,Jørn Brynskov,Klaus Bendtzen |
| Citations | 114 |
| DOI | 10.1097/ftd.0b013e31828d23c3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2333157326 |
| PMID | 23765033 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Tobias Wirenfeldt Klausen](https://scholariq.org/researchers/tobias-wirenfeldt-klausen/)

## Paper journal

- [Therapeutic Drug Monitoring](https://scholariq.org/journals/therapeutic-drug-monitoring/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.